Nothing Special   »   [go: up one dir, main page]

PT652874E - 2-heterociclico-5-hidroxi-1,3-pirimidinas uteis como agentes anti-inflamatorios - Google Patents

2-heterociclico-5-hidroxi-1,3-pirimidinas uteis como agentes anti-inflamatorios

Info

Publication number
PT652874E
PT652874E PT93918407T PT93918407T PT652874E PT 652874 E PT652874 E PT 652874E PT 93918407 T PT93918407 T PT 93918407T PT 93918407 T PT93918407 T PT 93918407T PT 652874 E PT652874 E PT 652874E
Authority
PT
Portugal
Prior art keywords
heterocyclic
pyrimidines
hydroxy
inflammatory agents
compounds
Prior art date
Application number
PT93918407T
Other languages
English (en)
Inventor
Paul Charles Unangst
Catherine Rose Kostlan
David Thomas Connor
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PT652874E publication Critical patent/PT652874E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT93918407T 1992-08-03 1993-07-27 2-heterociclico-5-hidroxi-1,3-pirimidinas uteis como agentes anti-inflamatorios PT652874E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/924,212 US5240929A (en) 1992-08-03 1992-08-03 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents

Publications (1)

Publication Number Publication Date
PT652874E true PT652874E (pt) 2004-03-31

Family

ID=25449891

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93918407T PT652874E (pt) 1992-08-03 1993-07-27 2-heterociclico-5-hidroxi-1,3-pirimidinas uteis como agentes anti-inflamatorios

Country Status (12)

Country Link
US (2) US5240929A (pt)
EP (1) EP0652874B1 (pt)
JP (1) JP3223190B2 (pt)
KR (1) KR100275428B1 (pt)
AT (1) ATE253571T1 (pt)
AU (1) AU672619B2 (pt)
CA (1) CA2139731C (pt)
DE (1) DE69333285T2 (pt)
DK (1) DK0652874T3 (pt)
ES (1) ES2206460T3 (pt)
PT (1) PT652874E (pt)
WO (1) WO1994003448A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0569493A4 (en) * 1991-01-31 1993-11-24 Warner-Lambert Company Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
ATE366569T1 (de) 2000-07-20 2007-08-15 Lauras As Verwendung von cox-2 inhibitoren als immunostimulantien zur behandlung von hiv oder aids
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
NZ530772A (en) * 2001-08-13 2006-03-31 Janssen Pharmaceutica Nv 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
DE10329955A1 (de) * 2003-07-03 2005-02-03 Merck Patent Gmbh Verwendung eines hydroalkoholischen Extrakts aus Bauhinia zur Herstellung einer Zubereitung
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
DK1919290T3 (da) * 2005-07-12 2014-04-22 Ampio Pharmaceuticals Inc Fremgangsmåder og produkter til behandling af sygdomme
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
MY198422A (en) 2009-04-29 2023-08-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US9675587B2 (en) 2013-03-14 2017-06-13 Allergan Holdings Unlimited Company Opioid receptor modulator dosage formulations
WO2023003497A1 (ru) * 2021-07-23 2023-01-26 Общество С Ограниченной Ответственностью "Валента-Интеллект" Соединения с лизосомотропной и противовирусной активностью

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636516A (en) * 1981-02-19 1987-01-13 Yamanouchi Pharmaceutical Co., Ltd. 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds

Also Published As

Publication number Publication date
DE69333285D1 (de) 2003-12-11
JPH08500101A (ja) 1996-01-09
CA2139731C (en) 2004-01-13
US5240929A (en) 1993-08-31
EP0652874B1 (en) 2003-11-05
AU4787093A (en) 1994-03-03
ATE253571T1 (de) 2003-11-15
KR950702554A (ko) 1995-07-29
US5312821A (en) 1994-05-17
DE69333285T2 (de) 2004-08-26
EP0652874A1 (en) 1995-05-17
KR100275428B1 (ko) 2000-12-15
JP3223190B2 (ja) 2001-10-29
DK0652874T3 (da) 2004-03-22
ES2206460T3 (es) 2004-05-16
CA2139731A1 (en) 1994-02-17
AU672619B2 (en) 1996-10-10
WO1994003448A1 (en) 1994-02-17

Similar Documents

Publication Publication Date Title
MX9102209A (es) Derivados de acido hidroxamico y n-hidroxiurea novedosos y su uso.
ES2075845T3 (es) 3,5-di-terc-butil-4-hidroxifenil-1,3,4-tiadiazoles, oxadiazoles y 3,5-di-terc-butil-4-hidroxifenil-1,2,4-tiadiazoles, oxadiazoles y triazoles como agentes antiinflamatorios.
PT652874E (pt) 2-heterociclico-5-hidroxi-1,3-pirimidinas uteis como agentes anti-inflamatorios
FI956119A0 (fi) Fenyyliheterosyklejä syklo-oksigenaasi-2-inhibiittoreina
EA200200708A1 (ru) Производные бензазола и их применение в качестве модуляторов jnk
PT752987E (pt) Derivados de pirimidinilo como inibidores da interleucina
ATE294800T1 (de) N-(5-(((5-alkyl-2-oxazolyl)methyl)thio)-2- thiazolyl)-carboxamide als inhibitoren cyclinabhängiger kinasen
HUP0402352A2 (hu) Foszfodiészteráz (PDE) 7 inhibitorként alkalmazható pirimidinszármazékok és ezeket tartalmazó gyógyszerkészítmények
NO960393L (no) Heterosykliske fenylforbindelser som COX-2-inhibitorer
BR9710737A (pt) Pentafluorobenzenosulfonamidas e análogos.
BR0108816A (pt) Derivados de quinolina como antagonistas alfa-2
AR030563A1 (es) N-[5-[[[5-alquil-2-oxazolil]metil]tio]-2-tiazolil]carboxamidas inhibidoras de cinasas dependientes de la ciclina y composiciones farmaceuticas que las contienen
SE9703414D0 (sv) New compounds
MX9205123A (es) Derivados de 5-hidroxi-2-pirimidinilmetileno utiles como agentes anti-inflamatorios.
ATE266027T1 (de) Optisch aktives pyridyl-4h-1,2,4-oxadiazinderivat und seine verwendung zur behandlung von gefässkrankheiten
ATE223376T1 (de) Bisarylcyclobutenderivate als cyclooxygenasehemmer
ATE16150T1 (de) Xanthinoxydasehemmer und verwendung von benztriazinderivaten.
ES2059204T3 (es) Derivados del acido hidroxamico inhibidores de lipoxigenasa.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
DE69811734D1 (de) Carboxylsäure substituierte heterocyclische verbindungen als metalloproteinase inhibitoren
SE9902596D0 (sv) Pharmaceutically active compounds